Key Segments:
By Product
-
IVL Catheters/Balloons
-
IVL Generators & Consoles
-
Guidewires & Accessories
By Type
-
Coronary IVL
-
Peripheral IVL
-
Others
By Application
-
Coronary Artery Disease
-
Peripheral Artery Disease
-
Below-the-Knee (BTK) Arterial Disease
-
Others
By End-User
-
Hospitals
-
Ambulatory Surgical Centers
-
Cardiac Catheterization Laboratories
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
Saudi Arabia
-
UAE
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company's specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Johnson & Johnson MedTech (Shockwave Medical), Boston Scientific Corporation, Abbott Laboratories, Stryker Corporation, and Koninklijke Philips N.V., among others.
Key opportunities include expanding peripheral and coronary applications, rising adoption of minimally invasive calcium modification, technological advancements, and increasing demand for effective treatment of severely calcified lesions.
The major growth factor is rising prevalence of severely calcified coronary and peripheral artery disease, rapid technology consolidation among major medical device companies, and growing clinical adoption of IVL as a first-line calcium-modification strategy.
The IVL Catheters/Balloons segment dominated the Intravascular Lithotripsy Market by product, representing the largest share of revenue in 2025.
North America dominated the Intravascular Lithotripsy Market in 2025, holding an estimated 58.0% share of total global market revenue.
